Form 4: Johnson & Johnson CEO Joaquin Duato Reports Stock Transactions
SEC Form 4 Filing
Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, reports multiple transactions involving the acquisition and disposal of company stock and derivative securities.
Summary
- Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, filed a Form 4 detailing changes in beneficial ownership.
- The report includes transactions from February 13, 2025, to February 18, 2025.
- These transactions involve the vesting of Restricted Share Units (RSUs) and Performance Share Units (PSUs) awarded under Johnson & Johnson's Long-Term Incentive Plan.
- Shares were also withheld for payment of taxes upon the vesting of RSUs and PSUs.
- Duato's direct holdings of common stock changed from 392,498 to 415,205 due to acquisitions, and then decreased to 395,923 due to disposals.
- He also holds 946 shares indirectly through a 401k plan.
- The transactions include the conversion of RSUs and PSUs into common stock at a price of $0, and the subsequent disposal of shares to cover tax obligations at prices ranging from $155.26 to $156.71.
- The filing also indicates that Duato holds derivative securities in the form of Restricted Share Units and Performance Share Units.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports routine stock transactions related to executive compensation. There are no indications of significant positive or negative developments.
Positives
- The vesting of RSUs and PSUs indicates that Duato is meeting the requirements of the company's Long-Term Incentive Plan.
- Duato's continued holdings in Johnson & Johnson stock align his interests with those of shareholders.
Negatives
- The disposal of shares to cover tax obligations, while common, reduces Duato's overall holdings in the company.
Risks
- Significant stock transactions by company executives can sometimes be perceived negatively by investors, although these transactions appear to be routine vesting and tax-related disposals.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often tied to compensation plans and regulatory requirements. These transactions provide insights into executive compensation and alignment with shareholder interests.
Comparison to Industry Standards
- Executive compensation packages at large pharmaceutical companies like Johnson & Johnson typically include a mix of salary, stock options, and restricted stock units.
- Vesting schedules for RSUs and PSUs are often structured to incentivize long-term performance and retention, similar to practices at companies like Pfizer and Merck.
- Tax-related stock disposals are a standard part of executive compensation, reflecting the tax obligations associated with vesting equity awards.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the CEO's compensation and alignment with company performance.
- Employees participating in the Johnson & Johnson Savings Plan may be indirectly affected by the dividend reinvestment.
Key Dates
| Date | Description |
|---|---|
| 01/31/2025 | Plan's most recent reporting date for dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan. |
| 02/13/2023 | Date of RSU award that vests in three annual equal installments beginning on the first anniversary of the grant date. |
| 02/13/2025 | Transaction date for the vesting of 3,470 Restricted Share Units. |
| 02/14/2022 | Date of RSU and PSU awards that vest three years after the date of grant. |
| 02/14/2025 | Transaction date for multiple events: disposal of 1,510 shares for taxes, vesting of 5,053 RSUs, disposal of 2,198 shares for taxes, vesting of 19,282 PSUs, and disposal of 8,386 shares for taxes. |
| 02/15/2024 | Date of RSU award that vests in three annual equal installments beginning on the first anniversary of the grant date. |
| 02/15/2025 | Transaction date for the vesting of 3,682 Restricted Share Units. |
| 02/18/2025 | Transaction date for the disposal of 1,602 shares for taxes. |
Keywords
Form 4, Johnson & Johnson, JNJ, Joaquin Duato, CEO, Chairman, Stock, RSU, PSU, Beneficial Ownership, Long-Term Incentive Plan, Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.